These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33340417)

  • 1. SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development.
    Rodriguez-Coira J; Sokolowska M
    Allergy; 2021 Jun; 76(6):1922-1924. PubMed ID: 33340417
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccines: call for global push to maintain efficacy.
    Stöhr K; Cox N
    Nature; 2021 Feb; 590(7844):36. PubMed ID: 33531701
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Red
    MMW Fortschr Med; 2020 Apr; 162(7):56. PubMed ID: 32291653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Facharztmagazine R
    MMW Fortschr Med; 2021 Apr; 163(7):66. PubMed ID: 33844237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in the development of coronavirus disease 2019 vaccine].
    Hu LF; Zhu MY; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):150-153. PubMed ID: 33548966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Canaday DH; Gravenstein S
    Clin Infect Dis; 2021 Feb; 72(3):513-514. PubMed ID: 33527123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible method for the production of a Covid-19 vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Mar; 186(12):388. PubMed ID: 32221001
    [No Abstract]   [Full Text] [Related]  

  • 11. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
    de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
    Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 16. Mix-and-match COVID vaccines trigger potent immune response.
    Callaway E
    Nature; 2021 May; 593(7860):491. PubMed ID: 34012131
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
    Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
    Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.
    Kar S; Islam R
    Bioanalysis; 2020 Sep; 12(17):1199-1203. PubMed ID: 32453605
    [No Abstract]   [Full Text] [Related]  

  • 20. "Let me choose my COVID-19 vaccine".
    Dal-Ré R; Stephens R; Sreeharan N
    Eur J Intern Med; 2021 May; 87():104-105. PubMed ID: 33581978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.